Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹9,177 Cr
Revenue (TTM)
₹4,261 Cr
Net Profit (TTM)
₹266 Cr
ROE
8.9 %
ROCE
11.2 %
P/E Ratio
34.6
P/B Ratio
3
Industry P/E
33.51
EV/EBITDA
16.8
Div. Yield
0.9 %
Debt to Equity
0.3
Book Value
₹193.9
EPS
₹17.3
Face value
1
Shares outstanding
159,281,139
CFO
₹1,965.56 Cr
EBITDA
₹2,436.13 Cr
Net Profit
₹1,272.47 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Jubilant Ingrevia
| -18.1 | -8.9 | -16.7 | -13.9 | 11.9 | -- | -- |
|
BSE Commodities
| -2.3 | -5.5 | 0.6 | 12.2 | 16.1 | 13.6 | 16.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Jubilant Ingrevia
| -14.6 | 61.5 | -3.8 | -7.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Jubilant Ingrevia
|
576.2 | 9,177.0 | 4,260.9 | 265.7 | 9.0 | 9.2 | 34.6 | 3.0 |
| 432.9 | 15,694.9 | 8,045.0 | 378.0 | 7.8 | 6.6 | 41.5 | 2.7 | |
| 1,068.6 | 14,162.4 | 1,088.6 | 215.8 | 27.4 | 9.8 | 65.6 | 5.9 | |
| 1,240.4 | 14,086.5 | 2,229.8 | 229.1 | 18.1 | 5.7 | 81.9 | 4.3 | |
| 715.7 | 7,603.1 | 970.8 | 245.5 | 29.8 | 16.8 | 31 | 4.9 | |
| 1,413.3 | 19,290.8 | 7,946.4 | 533.3 | 8.9 | 9.9 | 36.2 | 3.4 | |
| 4,320.1 | 13,244.3 | 2,347.3 | 398.8 | 17.9 | 16.4 | 33.4 | 5.2 | |
| 3,879.1 | 9,018.4 | 2,071.4 | 307.8 | 17.4 | 12.6 | 29.3 | 3.5 | |
| 2,996.8 | 11,694.6 | 2,455.7 | 286.6 | 18.6 | 25.6 | 38.9 | 8.9 | |
| 1,430.5 | 14,840.8 | 2,271.4 | 442.9 | 24.7 | 15.5 | 33.5 | 4.9 |
Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical intermediates. The Specialty Chemicals segment offers... pyridine and picolines, fine chemicals, crop protection chemicals, and custom development and manufacturing services. The Nutrition & Health Solutions segment provides nutrition and health ingredients, animal nutrition and health solutions, and human nutrition and health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol. The company also offers cyanopyridines, piperidines, acetyl pyridines, amino pyridines, halo pyridines, pyridine aldehydes, metal complexes, amino pyridines, dione salts, alkyl pyridines, vitamin B3, Vitamin B4, picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, and ethanol. In addition, it provides route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company offers vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, animal and human nutrition, agrochemical, personal and consumer care, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is based in Noida, India. Read more
Incorporated
2019
Chairman
Shyam S Bhartia
Managing Director
Deepak Jain
Group
Jubilant Bhartia
Headquarters
Amroha District, Uttar Pradesh
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Jubilant Ingrevia Ltd is ₹576.15 (NSE) and ₹576.15 (BSE) as of 18-Mar-2026 IST. Jubilant Ingrevia Ltd has given a return of 11.95% in the last 3 years.
The P/E ratio of Jubilant Ingrevia Ltd is 34.56 times as on 18-Mar-2026, a 3 premium to its peers’ median range of 33.51 times.
The P/B ratio of Jubilant Ingrevia Ltd is 2.97 times as on 18-Mar-2026, a 44 premium to its peers’ median range of 2.06 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
40.91
|
3.53
|
|
2024
|
39.02
|
2.62
|
|
2023
|
18.60
|
2.15
|
|
2022
|
15.00
|
2.94
|
|
2021
|
76.51
|
2.16
|
The 52-week high and low of Jubilant Ingrevia Ltd are Rs 851.80 and Rs 535.20 as of 19-Mar-2026.
Jubilant Ingrevia Ltd has a market capitalisation of ₹ 9,177 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Jubilant Ingrevia Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹11.50
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.